Novo Nordisk · 13 hours ago
Internship - Government Pricing, Contracts & Operations
Novo Nordisk is a global pharmaceutical company focused on defeating serious chronic diseases and improving health outcomes. The internship position within the Government Pricing, Contracts & Operations team offers students the opportunity to gain hands-on experience while contributing to meaningful projects in a dynamic business environment.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Work closely with experienced industry professionals and gain valuable, hands-on, full-time work experience
Contribute to the line of business by providing sustainable and meaningful project work
Participate in the program's capstone event, the Innovation in Action Case Competition
Assigned to cross-functional teams, work closely to develop an innovative and comprehensive solution to a business problem currently facing Novo Nordisk
Present findings to a board of top Novo Nordisk officials representing the various lines of business
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than April 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate or graduate degree in Business Administration, Finance or a related discipline preferred
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase